Guardian Pharmacy Services (GRDN) reported preliminary Q4 income Monday of $10.1 million to $11.1 million, down by $3.5 million to $4.5 million from a year earlier.
Three analysts polled by FactSet expect $10.5 million.
Revenue for the quarter ended Dec. 31 is expected to be $338.6 million, up 20.5% from a year earlier.
Three analysts surveyed by FactSet expect $320.5 million.
For 2025, the company expects revenue of $1.33 billion to $1.35 billion. Three analysts polled by FactSet expect $1.33 billion.
Shares of the company were down nearly 10% in recent premarket activity.
Price: 18.01, Change: -1.99, Percent Change: -9.95
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。